| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/19/2013 | US8377690 Cells and methods for producing blocking antibodies to human RANKL |
| 02/19/2013 | US8377679 Use of probiotic lactic acid bacteria for balancing the skin's immune system |
| 02/19/2013 | CA2573371C Pyrimidines as plk inhibitors |
| 02/19/2013 | CA2486187C Kinase inhibitors |
| 02/19/2013 | CA2276450C A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent |
| 02/14/2013 | WO2013022996A2 The utility of nematode small molecules |
| 02/14/2013 | WO2013022243A2 Novel biphenyl derivative or a pharmaceutically acceptable salt thereof, and pharmaceutical composition for preventing or treating inflammatory diseases or autoimmune diseases comprising same as an active ingredient |
| 02/14/2013 | WO2013022238A2 Tricyclic glycosylated derivative compound, a production method therefor, and an immunosuppressant pharmaceutical composition comprising a tacrolimus glycosylation derivative |
| 02/14/2013 | WO2013022091A1 Therapeutic agent for autoimmune diseases comprising pd-1 agonist |
| 02/14/2013 | WO2013021784A1 Immune tolerance inducer |
| 02/14/2013 | WO2013021021A1 Novel soft pde4 inhibitors |
| 02/14/2013 | WO2013020995A1 New antibodies against phosphorylcholine |
| 02/14/2013 | WO2013020371A1 Pim kinase inhibitor, preparation method and use thereof in drug preparation |
| 02/14/2013 | WO2013020370A1 Pim kinase inhibitor and preparation method and use in medicinal manufacture thereof |
| 02/14/2013 | WO2013020235A1 Methods and compositions for modulating voltage-gated calcium channel function |
| 02/14/2013 | US20130042334 Capping-Prone RNA Polymerase Enzymes and Their Applications |
| 02/14/2013 | US20130041349 Substitute therapy for glucocorticoids |
| 02/14/2013 | US20130041006 Pharmaceutical composition for intracellar acidification with cis-urocanic acid |
| 02/14/2013 | US20130041005 Pharmaceutical compositions comprising neuropilin inhibitors, and their use for the prevention and/or treatment of angiogenic disorders and cancers |
| 02/14/2013 | US20130041003 Bendamustine Pharmaceutical Compositions |
| 02/14/2013 | US20130040984 7-(lH-PYRAZOL-4-YL)-1,6-NAPHTHYRIDINE COMPOUNDS AS SYK INHIBITORS |
| 02/14/2013 | US20130040980 Cci-779 concentrate formulations |
| 02/14/2013 | US20130040974 Piperidine inhibitors of janus kinase 3 |
| 02/14/2013 | US20130040933 Azaindoles as janus kinase inhibitors |
| 02/14/2013 | US20130040930 Novel amide derivative and use thereof as medicine |
| 02/14/2013 | US20130040912 Piperazinotriazines as pi3k inhibitors for use in the treatment antiproliferative disorders |
| 02/14/2013 | US20130040908 Substitution derivatives of n6-benzyladenosine-5' -monophosphate, methods of preparation thereof, use thereof as medicaments, and therapeutic preparations containing these compounds |
| 02/14/2013 | US20130040905 Combination Of Drugs With Protein-Binding Prodrugs |
| 02/14/2013 | US20130040900 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 02/14/2013 | US20130040892 Iap bir domain binding compounds |
| 02/14/2013 | US20130039987 Method for increasing the solubility of a transcriptase inhibitor composition |
| 02/14/2013 | US20130039981 Quick Dissolving, Long Acting Zinc Therapeutic Formulations |
| 02/14/2013 | US20130039958 Method of vaccination |
| 02/14/2013 | US20130039954 Control of antibody responses to synthetic nanocarriers |
| 02/14/2013 | US20130039951 Process Of Preparing A Stabilized And Solubilized Formulation Of Sirolimus Derivatives |
| 02/14/2013 | US20130039949 Immunomodulating compounds and related compositions and methods |
| 02/14/2013 | US20130039948 Inhibition of TCR Signaling with Peptide Variants |
| 02/14/2013 | US20130039946 Vaccine comprising an attenuated pestivirus |
| 02/14/2013 | US20130039944 Anti-Viral Compounds |
| 02/14/2013 | US20130039941 Vaccine comprising inactivated cells of haemophilus parasuis bacteria of serotype 5 |
| 02/14/2013 | US20130039940 Homogenous Vaccine Composition Comprising a Conjugate of EGF and P64K for the Treatment of Tumors |
| 02/14/2013 | US20130039938 Highly efficient influenza matrix (m1) proteins |
| 02/14/2013 | US20130039935 Induction of tumor immunity by variants of folate binding protein |
| 02/14/2013 | US20130039934 Treatment of ige-mediated disease |
| 02/14/2013 | US20130039933 Sting (stimulator of interferon genes), a regulator of innate immune responses |
| 02/14/2013 | US20130039928 Compositions and methods for reversing corticosteroid resistance or treating respiratory infections |
| 02/14/2013 | US20130039927 Antigenic mimics of discontinuous epitopes of pathogen recognized by broadly neutralizing antibodies |
| 02/14/2013 | US20130039925 Alternative pathway specific antibodies for treating arthritis |
| 02/14/2013 | US20130039923 Anti-human interleukin-20 antibodies |
| 02/14/2013 | US20130039918 Pharmaceutical Composition Using Connective-tissue Growth Factor |
| 02/14/2013 | US20130039916 ENGINEERED ANTI-IL-23p19 ANTIBODIES |
| 02/14/2013 | US20130039906 PYRAZOLO[3,4-c]PYRIDINE COMPOUNDS AND METHODS OF USE |
| 02/14/2013 | US20130039897 Compositions and methods for regulating neutrophil movement and neutrophil numbers in a body region |
| 02/14/2013 | US20130039892 Adherent stromal cells derived from plancentas of multiple donors and uses thereof |
| 02/14/2013 | US20130039886 Beta-mannosylceramide and stimulation of nkt cell anti-tumor immunity |
| 02/14/2013 | US20130039885 Leukotoxin e/d as a new anti-inflammatory agent and microbicide |
| 02/14/2013 | US20130039850 Heterologous antibodies which bind human cd4 |
| 02/14/2013 | US20130039848 Fluorescent silica-based nanoparticles |
| 02/14/2013 | CA2851575A1 Methods and compositions for inhibiting delayed graft function |
| 02/14/2013 | CA2844855A1 Pim kinase inhibitors and preparation methods and use in medicinal manufacture thereof |
| 02/14/2013 | CA2844852A1 Pim kinase inhibitors and preparation methods and use in medicinal manufacture thereof |
| 02/14/2013 | CA2844668A1 Methods and compositions for the treatment of autoimmune and inflammatory diseases |
| 02/14/2013 | CA2843921A1 New antibodies against phosphorylcholine |
| 02/14/2013 | CA2842853A1 Novel soft pde4 inhibitors |
| 02/14/2013 | CA2841874A1 Methods and compositions for modulating voltage-gated calcium channel function |
| 02/13/2013 | EP2557154A2 Method for increasing activity in human stem cell |
| 02/13/2013 | EP2556835A1 Mixture, dissolving solution and pharmaceutical agent each comprising thermophilic microorganism |
| 02/13/2013 | EP2556088A1 Plasma-derived immunoglobulin for use in the treatment and prevention of immune reconstitution inflammatory syndrome (iris) |
| 02/13/2013 | EP2556054A1 Diastereomers of 2-methylene-19-nor-22-methyl-1alpha,25-dihydroxyvitamin d3 |
| 02/13/2013 | EP2556053A2 (20s)-2-methylene-19-nor-22-dimethyl-1alpha,25- dihydroxyvitamin d3 and (20r)-2-methylene-19-nor-22-dimethyl-1alpha,25-hydroxyvitamin d3 |
| 02/13/2013 | EP2555790A1 THERAPEUTIC USE OF THE ß2m PROTEIN |
| 02/13/2013 | EP2555627A1 Methods of treating cancer |
| 02/13/2013 | CN102933561A Pharmaceutically active disubstituted triazine derivatives |
| 02/13/2013 | CN102925403A Recombinant strain capable of expressing fungal immunomodulatory protein from Flammulina velutipes (FIP-fve), construction method, protein expression and purification method, and protein application |
| 02/13/2013 | CN102924622A Helianthus annuus polysaccharide and preparation method thereof |
| 02/13/2013 | CN102924619A Agaricus blazei murill extract and preparation method thereof |
| 02/13/2013 | CN102924599A Antibody, as well as application and preparation method thereof |
| 02/13/2013 | CN102924458A 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors |
| 02/13/2013 | CN102924446A PIM kinase inhibitor, preparation method thereof, and application thereof in pharmacy |
| 02/13/2013 | CN102924445A PIM kinase inhibitor, preparation method thereof, and application thereof in pharmacy |
| 02/13/2013 | CN102924444A PIM kinase inhibitor, preparation method thereof, and application thereof in pharmacy |
| 02/13/2013 | CN102924363A Crystal forms of saxagliptin and processes for preparing same |
| 02/13/2013 | CN102921003A Stabilized immune modulatory RNA (SIMRA) compounds |
| 02/13/2013 | CN102920946A Preparation method of Chinese herbal medicinal active fermentation broth for preventing and treating porcine infectious diseases |
| 02/13/2013 | CN102920920A Efficient powerful rhizoma gastrodiae and cortex eucommiae soft capsule or preparation |
| 02/13/2013 | CN102920912A Medicinal composition for enhancing immunologic functions of human bodies |
| 02/13/2013 | CN102920859A Medicine for preventing pouen allergy |
| 02/13/2013 | CN102920847A Composition for strengthening immunity and preparation and application thereof |
| 02/13/2013 | CN102920836A Traditional Chinese medicine composite for treating immune thrombocytopenic purpura |
| 02/13/2013 | CN102920786A Method for preparing preparation capable of protecting liver, resisting tumors, reducing blood lipid and regulating immunity |
| 02/13/2013 | CN102920783A Process for preparing effective components of schisandrachinensis |
| 02/13/2013 | CN102920772A Cordyceps militaris silk astragalus membranaceus capsule |
| 02/13/2013 | CN102920750A Health-care compound preparation for nourishing brain and improving eyesight |
| 02/13/2013 | CN102920749A Method for preparing fully-effective ganoderma lucidum health care product |
| 02/13/2013 | CN102920730A Application of agaricus blazei murill polysaccharide extracts in lipid-lowering drug preparation |
| 02/13/2013 | CN102920728A Application of baicalin in manufacturing of drugs |
| 02/13/2013 | CN102920711A Combination of benzophenone derivative or salt thereof and immunosuppressing agent, and pharmaceutical composition comprising these components |
| 02/13/2013 | CN102920693A Longan flower extract, application of longan flower extract in immunoloregulation, and longan flower extract preparation method |
| 02/13/2013 | CN102920674A Technology for preparing hydroxychloroquine sulfate tablets |
| 02/13/2013 | CN102920643A Seabuckthorn pain relieving bath foam |